GSA Capital Partners’s OrthoPediatrics KIDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-15,726
Closed -$250K – 1960
2026
Q1
$250K Sell
15,726
-8,285
-35% -$145K 0.02% 1346
2025
Q4
$426K Buy
+24,011
New +$420K 0.04% 926
2022
Q3
– Sell
-5,242
Closed -$226K – 1704
2022
Q2
$226K Sell
5,242
-12,870
-71% -$589K 0.03% 1014
2022
Q1
$978K Buy
18,112
+7,080
+64% +$362K 0.13% 188
2021
Q4
$660K Buy
11,032
+2,651
+32% +$165K 0.08% 412
2021
Q3
$549K Sell
8,381
-14,706
-64% -$955K 0.06% 644
2021
Q2
$1.46M Sell
23,087
-8,281
-26% -$476K 0.16% 128
2021
Q1
$1.53M Buy
+31,368
New +$1.51M 0.25% 79
2018
Q3
– Sell
-22,999
Closed -$613K – 1764
2018
Q2
$613K Buy
+22,999
New +$491K 0.03% 1047

Other funds holding KIDS

GSA Capital Partners's KIDS Position: Q2 2026 in Review

GSA Capital Partners sold out of OrthoPediatrics (KIDS) in Q2 2026, closing a stake of 15,726 shares — an estimated $250K sold.

GSA Capital Partners first reported a position in KIDS in Q2 2018 and held it in 9 quarters. The position peaked at $1.53M in Q1 2021. 119 funds tracked by Wall St. Rank hold KIDS as of Q2 2026.

  • GSA Capital Partners reported no remaining OrthoPediatrics position as of Q2 2026 after selling out during the quarter.
  • GSA Capital Partners sold 15,726 OrthoPediatrics shares in Q2 2026, an estimated $250K.
  • GSA Capital Partners first reported a position in OrthoPediatrics in Q2 2018 and held it in 9 quarters.
  • GSA Capital Partners's OrthoPediatrics position peaked at $1.53M in Q1 2021.
  • 119 funds tracked by Wall St. Rank held OrthoPediatrics as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.